
European Innovation Council (EIC)
The European Innovation Council (EIC) focuses its investments on deep-tech, disruptive, and market-creating innovations from startups and SMEs across all sectors, with an emphasis on strategic areas like health, green deal, and digital transformation. Its strategy involves providing blended finance (grants and equity) through the EIC Accelerator to bridge the gap between innovation and commercialization, de-risking projects, and catalyzing private co-investment to help companies scale up and retain intellectual property in Europe.
32% of their portfolio is in Hardware & Semiconductors. Deal activity increased 62% year-over-year (34 deals in the last 12 months). Their most common stage is series-a (44% of deals). Average disclosed round size is $32.3M (across 74 rounds with reported amounts).
Portfolio
80
Fund Size
$4B
Top Stage
Series A
Last 12 Mo
34
Team
Portfolio Breakdown
Stage Distribution
Sector Distribution
Investment Activity
Portfolio
| Company | Round | Amount | Date |
|---|---|---|---|
| NneuroClues | Series A | — | Apr 2026 |
| AArkadia Space | Series A | $15.7M | Mar 2026 |
| Series A | $7M | Mar 2026 | |
| Series C | — | Feb 2026 | |
| Series A | $37M | Feb 2026 | |
| RR3 Robotics | Series A | $14M | Feb 2026 |
| Seed | $10M | Feb 2026 | |
| RR3 Robotics | Series A | $20M | Feb 2026 |
| MMelt&Marble | Series A | $7.3M | Dec 2025 |
| IIQM Quantum Computers | Unknown | — | Nov 2025 |
| IInfinite Orbits | Growth | $40M | Nov 2025 |
| Unknown | $20M | Nov 2025 | |
| FFerroelectric Memory GmbH (FMC) | Unknown | $100M | Nov 2025 |
| Growth | $104M | Oct 2025 | |
| DDracula Technologies | Series A | $30M | Oct 2025 |
| OOmnix Medical | Series C | $25M | Oct 2025 |
| Series A | $10.5M | Oct 2025 | |
| Unknown | $8M | Oct 2025 | |
| Series B | $87M | Sep 2025 | |
| Series A | $16M | Sep 2025 | |
| TTAFALGIE THERAPEUTICS | Series A | $12M | Sep 2025 |
| IIntegra Therapeutics | Pre-Seed | $10.7M | Sep 2025 |
| IIQM Quantum Computers | Series B | $275M | Sep 2025 |
| QQuiX Quantum | Series A | $15M | Jul 2025 |
| RRestore Medical Ltd | Series B | $23M | Jul 2025 |
Top Co-Investors
Last updated: 12 April 2026